Cargando…

Asymmetric synthesis of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates

This study describes general methods for the enantioselective syntheses of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates through dirhodium tetracarboxylate-catalysed asymmetric cyclopropanation of vinyl heterocycles with aryl- or heteroaryldiazoacetat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharland, Jack C., Wei, Bo, Hardee, David J., Hodges, Timothy R., Gong, Wei, Voight, Eric A., Davies, Huw M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386643/
https://www.ncbi.nlm.nih.gov/pubmed/34522315
http://dx.doi.org/10.1039/d1sc02474d
_version_ 1783742294714744832
author Sharland, Jack C.
Wei, Bo
Hardee, David J.
Hodges, Timothy R.
Gong, Wei
Voight, Eric A.
Davies, Huw M. L.
author_facet Sharland, Jack C.
Wei, Bo
Hardee, David J.
Hodges, Timothy R.
Gong, Wei
Voight, Eric A.
Davies, Huw M. L.
author_sort Sharland, Jack C.
collection PubMed
description This study describes general methods for the enantioselective syntheses of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates through dirhodium tetracarboxylate-catalysed asymmetric cyclopropanation of vinyl heterocycles with aryl- or heteroaryldiazoacetates. The reactions are highly diastereoselective and high asymmetric induction could be achieved using either (R)-pantolactone as a chiral auxiliary or chiral dirhodium tetracarboxylate catalysts. For meta- or para-substituted aryl- or heteroaryldiazoacetates the optimum catalyst was Rh(2)(R-p-Ph-TPCP)(4). In the case of ortho-substituted aryl- or heteroaryldiazoacetates, the optimum catalyst was Rh(2)(R-TPPTTL)(4). For a highly enantioselective reaction with the ortho-substituted substrates, 2-chloropyridine was required as an additive in the presence of either 4 Å molecular sieves or 1,1,1,3,3,3-hexafluoroisopropanol (HFIP). Under the optimized conditions, the cyclopropanation could be conducted in the presence of a variety of heterocycles, such as pyridines, pyrazines, quinolines, indoles, oxadiazoles, thiophenes and pyrazoles.
format Online
Article
Text
id pubmed-8386643
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-83866432021-09-13 Asymmetric synthesis of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates Sharland, Jack C. Wei, Bo Hardee, David J. Hodges, Timothy R. Gong, Wei Voight, Eric A. Davies, Huw M. L. Chem Sci Chemistry This study describes general methods for the enantioselective syntheses of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates through dirhodium tetracarboxylate-catalysed asymmetric cyclopropanation of vinyl heterocycles with aryl- or heteroaryldiazoacetates. The reactions are highly diastereoselective and high asymmetric induction could be achieved using either (R)-pantolactone as a chiral auxiliary or chiral dirhodium tetracarboxylate catalysts. For meta- or para-substituted aryl- or heteroaryldiazoacetates the optimum catalyst was Rh(2)(R-p-Ph-TPCP)(4). In the case of ortho-substituted aryl- or heteroaryldiazoacetates, the optimum catalyst was Rh(2)(R-TPPTTL)(4). For a highly enantioselective reaction with the ortho-substituted substrates, 2-chloropyridine was required as an additive in the presence of either 4 Å molecular sieves or 1,1,1,3,3,3-hexafluoroisopropanol (HFIP). Under the optimized conditions, the cyclopropanation could be conducted in the presence of a variety of heterocycles, such as pyridines, pyrazines, quinolines, indoles, oxadiazoles, thiophenes and pyrazoles. The Royal Society of Chemistry 2021-07-27 /pmc/articles/PMC8386643/ /pubmed/34522315 http://dx.doi.org/10.1039/d1sc02474d Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Sharland, Jack C.
Wei, Bo
Hardee, David J.
Hodges, Timothy R.
Gong, Wei
Voight, Eric A.
Davies, Huw M. L.
Asymmetric synthesis of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates
title Asymmetric synthesis of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates
title_full Asymmetric synthesis of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates
title_fullStr Asymmetric synthesis of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates
title_full_unstemmed Asymmetric synthesis of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates
title_short Asymmetric synthesis of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates
title_sort asymmetric synthesis of pharmaceutically relevant 1-aryl-2-heteroaryl- and 1,2-diheteroarylcyclopropane-1-carboxylates
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386643/
https://www.ncbi.nlm.nih.gov/pubmed/34522315
http://dx.doi.org/10.1039/d1sc02474d
work_keys_str_mv AT sharlandjackc asymmetricsynthesisofpharmaceuticallyrelevant1aryl2heteroaryland12diheteroarylcyclopropane1carboxylates
AT weibo asymmetricsynthesisofpharmaceuticallyrelevant1aryl2heteroaryland12diheteroarylcyclopropane1carboxylates
AT hardeedavidj asymmetricsynthesisofpharmaceuticallyrelevant1aryl2heteroaryland12diheteroarylcyclopropane1carboxylates
AT hodgestimothyr asymmetricsynthesisofpharmaceuticallyrelevant1aryl2heteroaryland12diheteroarylcyclopropane1carboxylates
AT gongwei asymmetricsynthesisofpharmaceuticallyrelevant1aryl2heteroaryland12diheteroarylcyclopropane1carboxylates
AT voighterica asymmetricsynthesisofpharmaceuticallyrelevant1aryl2heteroaryland12diheteroarylcyclopropane1carboxylates
AT davieshuwml asymmetricsynthesisofpharmaceuticallyrelevant1aryl2heteroaryland12diheteroarylcyclopropane1carboxylates